SemaThera Competitors and Similar CompaniesClear all
SemaThera's competitors and similar companies include Rebiotix and PellePharm.
 SemaThera SemaThera is a spin-off company focusing on SEMA 3A inhibitors in the treatment of ocular diseases. |  Rebiotix Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome. | ||
Founding Date | Founding Date 2016 | Founding Date 2011 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Westmount, CA HQ | Locations Saint Paul, US HQ | Locations San Francisco, US HQ |
Employees | Employees 6 | Employees 70 | Employees 5 |
Funding | |||
Latest funding round | Latest funding round $ 1m (over 9 years ago) | Latest funding round $ 25m (almost 12 years ago) | Latest funding round $ 70m (over 7 years ago) |
Total funding raised | Total funding raised $ 1m | Total funding raised $ 27.8m | Total funding raised $ 81.4m |
For sources of this data, please see the company profile
View Company Profiles
Rebiotix
HQ
Saint Paul, US
Employees
70
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
View company
PellePharm
HQ
San Francisco, US
Employees
5
PellePharm, Inc. operates in the biotechnology industry.
View company